Last quarter (Q2 2022), Uni-President China Holdings's total revenue was $13.94B, an increase of 17.97% from the same quarter last year. In Q2, Uni-President China Holdings's net income was $―. See Uni-President China Holdings’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 26.95B	$ 25.23B	$ 22.76B	$ 22.02B	$ 21.77B	$ 20.82B
Cost of Revenue	$ ―	$ 17.01B	$ 14.70B	$ 14.10B	$ 14.48B	$ 14.25B
Gross Profit	$ ―	$ 8.22B	$ 8.07B	$ 7.92B	$ 7.29B	$ 6.58B
Operating Expense	$ ―	$ 6.53B	$ 6.20B	$ 6.25B	$ 6.07B	$ 5.47B
Operating Income	$ ―	$ 1.69B	$ 1.87B	$ 1.66B	$ 1.22B	$ 1.11B
Net Non Operating Interest Income Expense	$ ―	$ 201.20M	$ 173.19M	$ 152.14M	$ 123.13M	$ 67.57M
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ ―	$ 2.14B	$ 2.33B	$ 1.97B	$ 1.54B	$ 1.28B
Tax Provision	$ ―	$ 641.13M	$ 700.76M	$ 605.15M	$ 510.07M	$ 398.61M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ 1.50B	$ 1.63B	$ 1.37B	$ 1.03B	$ 878.22M
Basic EPS	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted EPS	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Basic Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ 23.54B	$ 20.90B	$ 20.36B	$ 20.55B	$ 19.71B
Net Income From Continuing And Discontinued Operation	$ ―	$ 1.50B	$ 1.63B	$ 1.37B	$ 1.03B	$ 878.22M
Normalized Income	$ ―	$ 1.44B	$ 1.55B	$ 1.37B	$ 1.04B	$ 908.72M
Interest Expense	$ ―	$ 31.55M	$ 56.44M	$ 57.33M	$ 46.14M	$ 45.92M
EBIT	$ ―	$ 2.17B	$ 2.38B	$ 2.03B	$ 1.59B	$ 1.32B
EBITDA	$ ―	$ 3.40B	$ 3.67B	$ 3.41B	$ 2.95B	$ 2.72B

Currency in USD

Uni-President China Holdings Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing